The Conquer Cancer®, the ASCO Foundation, and Pfizer Inc. have launched a collaborative Quality Improvement grant opportunity designed to advance the use of digital technology to improve evidence-based biomarker testing and treatment practices. This initiative specifically targets colorectal, lung, and prostate cancers, aiming to close gaps in diagnostic testing and ensure timely, data-driven treatment decisions
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: